Early Protection Against Pathogenic Virus Infection at a Mucosal Challenge Site After Vaccination with Attenuated Simian Immunodeficiency Virus

Overview

Journal Proc Natl Acad Sci U S A

Specialty Science

Date 2004 Feb 19

PMID 14970317

Citations 35

Authors

Klara Tenner-Racz

Christiane Stahl Hennig

Klaus Uberla

Heribert Stoiber

Ralf Ignatius

Jonathan Heeney

Ralph M Steinman

Paul Racz

Affiliations

Soon will be listed here.

Abstract

Atraumatic application of attenuated SIVmac239 Delta nef vaccine to the tonsils of rhesus macaques provided protection against challenge 26 weeks later with infectious SIVmac251 applied through this route. Early events at the mucosal portal of entry of challenge virus were followed. Wild-type virus was detected in nonvaccinated controls by day 4, and then simian immunodeficiency virus (SIV) replicated vigorously at days 7 and 14. In contrast, a challenge of 10 of 10 vaccinees with SIV did not significantly raise RNA levels in the plasma or increase infected cells in lymphoid tissues, as assessed by single-cell labeling for viral RNA and nef protein. Vaccine virus was found in the tonsils of all vaccinees, but challenge virus was only detected at this portal of entry in 4 of 10 monkeys. In the tonsil, the challenge virus did not induce an expansion of perforin(+) killer cells. However, there was a significant increase in gamma delta T cells and mature dendritic cells relative to unvaccinated controls. Therefore, during tonsillar SIV Delta nef vaccination, infection is blocked early at the entry portal, which we propose is due in part to innate functions of gamma delta T and dendritic cells.

Citing Articles

Direct intranodal tonsil vaccination with modified vaccinia Ankara vaccine protects macaques from highly pathogenic SIVmac251.

Mattathil J, Volz A, Onabajo O, Maynard S, Bixler S, Shen X Nat Commun. 2023; 14(1):1264.

PMID: 36882405 PMC: 9990026. DOI: 10.1038/s41467-023-36907-0.

Localization of infection in neonatal rhesus macaques after oral viral challenge.

Taylor R, McRaven M, Carias A, Anderson M, Matias E, Arainga M PLoS Pathog. 2021; 17(11):e1009855.

PMID: 34793582 PMC: 8639050. DOI: 10.1371/journal.ppat.1009855.

How to Train Your Dragon: Harnessing Gamma Delta T Cells Antiviral Functions and Trained Immunity in a Pandemic Era.

Caron J, Ridgley L, Bodman-Smith M Front Immunol. 2021; 12:666983.

PMID: 33854516 PMC: 8039298. DOI: 10.3389/fimmu.2021.666983.

Microneedle-Mediated Vaccine Delivery to the Oral Mucosa.

Creighton R, Woodrow K Adv Healthc Mater. 2018; 8(4):e1801180.

PMID: 30537400 PMC: 6476557. DOI: 10.1002/adhm.201801180.

A simultaneous oral and intramuscular prime/sublingual boost with a DNA/Modified Vaccinia Ankara viral vector-based vaccine induces simian immunodeficiency virus-specific systemic and mucosal immune responses in juvenile rhesus macaques.

Curtis 2nd A, Jensen K, Van Rompay K, Amara R, Kozlowski P, De Paris K J Med Primatol. 2018; 47(5):288-297.

PMID: 30204253 PMC: 6158111. DOI: 10.1111/jmp.12372.

References

Lehner T, Bergmeier L, Wang Y, Tao L, Mitchell E . A rational basis for mucosal vaccination against HIV infection. Immunol Rev. 1999; 170:183-96. DOI: 10.1111/j.1600-065x.1999.tb01338.x. View

Weissman D, Ni H, Scales D, Dude A, Capodici J, McGibney K . HIV gag mRNA transfection of dendritic cells (DC) delivers encoded antigen to MHC class I and II molecules, causes DC maturation, and induces a potent human in vitro primary immune response. J Immunol. 2000; 165(8):4710-7. DOI: 10.4049/jimmunol.165.8.4710. View

Mascola J, Stiegler G, Vancott T, Katinger H, Carpenter C, Hanson C . Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies. Nat Med. 2000; 6(2):207-10. DOI: 10.1038/72318. View

Gundlach B, Lewis M, Sopper S, Schnell T, Sodroski J, Stahl-Hennig C . Evidence for recombination of live, attenuated immunodeficiency virus vaccine with challenge virus to a more virulent strain. J Virol. 2000; 74(8):3537-42. PMC: 111861. DOI: 10.1128/jvi.74.8.3537-3542.2000. View

Iwasaki A, Kelsall B . Localization of distinct Peyer's patch dendritic cell subsets and their recruitment by chemokines macrophage inflammatory protein (MIP)-3alpha, MIP-3beta, and secondary lymphoid organ chemokine. J Exp Med. 2000; 191(8):1381-94. PMC: 2193144. DOI: 10.1084/jem.191.8.1381. View

Metzner K, Jin X, Lee F, Gettie A, Bauer D, Di Mascio M . Effects of in vivo CD8(+) T cell depletion on virus replication in rhesus macaques immunized with a live, attenuated simian immunodeficiency virus vaccine. J Exp Med. 2000; 191(11):1921-31. PMC: 2213531. DOI: 10.1084/jem.191.11.1921. View

Lehner T, Mitchell E, Bergmeier L, Singh M, Spallek R, Cranage M . The role of gammadelta T cells in generating antiviral factors and beta-chemokines in protection against mucosal simian immunodeficiency virus infection. Eur J Immunol. 2000; 30(8):2245-56. DOI: 10.1002/1521-4141(2000)30:8<2245::AID-IMMU2245>3.0.CO;2-7. View

Hofmann-Lehmann R, Swenerton R, Liska V, Leutenegger C, Lutz H, McClure H . Sensitive and robust one-tube real-time reverse transcriptase-polymerase chain reaction to quantify SIV RNA load: comparison of one- versus two-enzyme systems. AIDS Res Hum Retroviruses. 2000; 16(13):1247-57. DOI: 10.1089/08892220050117014. View

Granelli-Piperno A, Zhong L, Haslett P, Jacobson J, Steinman R . Dendritic cells, infected with vesicular stomatitis virus-pseudotyped HIV-1, present viral antigens to CD4+ and CD8+ T cells from HIV-1-infected individuals. J Immunol. 2000; 165(11):6620-6. DOI: 10.4049/jimmunol.165.11.6620. View

10.

Zhong L, Granelli-Piperno A, Pope M, Ignatius R, Lewis M, FRANKEL S . Presentation of SIVgag to monkey T cells using dendritic cells transfected with a recombinant adenovirus. Eur J Immunol. 2000; 30(11):3281-90. DOI: 10.1002/1521-4141(200011)30:11<3281::AID-IMMU3281>3.0.CO;2-4. View

11.

Buseyne F, Le Gall S, Boccaccio C, Abastado J, Lifson J, Arthur L . MHC-I-restricted presentation of HIV-1 virion antigens without viral replication. Nat Med. 2001; 7(3):344-9. DOI: 10.1038/85493. View

12.

Geijtenbeek T, Krooshoop D, Bleijs D, van Vliet S, van Duijnhoven G, Grabovsky V . DC-SIGN-ICAM-2 interaction mediates dendritic cell trafficking. Nat Immunol. 2001; 1(4):353-7. DOI: 10.1038/79815. View

13.

Worku S, Gorse G, Belshe R, Hoft D . Canarypox vaccines induce antigen-specific human gammadelta T cells capable of interferon-gamma production. J Infect Dis. 2001; 184(5):525-32. DOI: 10.1086/322792. View

14.

Stahl-Hennig C, Steinman R, Haaft P, Uberla K, Stolte N, Saeland S . The simian immunodeficiency virus deltaNef vaccine, after application to the tonsils of Rhesus macaques, replicates primarily within CD4(+) T cells and elicits a local perforin-positive CD8(+) T-cell response. J Virol. 2001; 76(2):688-96. PMC: 136843. DOI: 10.1128/jvi.76.2.688-696.2002. View

15.

Carding S, Egan P . Gammadelta T cells: functional plasticity and heterogeneity. Nat Rev Immunol. 2002; 2(5):336-45. DOI: 10.1038/nri797. View

16.

Stebbings R, Almond N, Stott E, Berry N, Hull R, Lines J . Mechanisms of protection induced by attenuated simian immunodeficiency virus. Virology. 2002; 296(2):338-53. DOI: 10.1006/viro.2002.1379. View

17.

Leslie D, Vincent M, Spada F, Das H, Sugita M, Morita C . CD1-mediated gamma/delta T cell maturation of dendritic cells. J Exp Med. 2002; 196(12):1575-84. PMC: 2196072. DOI: 10.1084/jem.20021515. View

18.

Cameron P, Freudenthal P, Barker J, Gezelter S, Inaba K, Steinman R . Dendritic cells exposed to human immunodeficiency virus type-1 transmit a vigorous cytopathic infection to CD4+ T cells. Science. 1992; 257(5068):383-7. DOI: 10.1126/science.1352913. View

19.

Daniel M, Kirchhoff F, Czajak S, Sehgal P, Desrosiers R . Protective effects of a live attenuated SIV vaccine with a deletion in the nef gene. Science. 1992; 258(5090):1938-41. DOI: 10.1126/science.1470917. View

20.

Tenner-Racz K, von Stemm A, Guhlk B, Schmitz J, Racz P . Are follicular dendritic cells, macrophages and interdigitating cells of the lymphoid tissue productively infected by HIV?. Res Virol. 1994; 145(3-4):177-82. DOI: 10.1016/s0923-2516(07)80020-3. View